Editorial: Tailored screening for breast cancer in premenopausal women: Not just looking at sensitivity, but aiming to reduce burden

Women's Health

Volumn 6, Issue 4, 2010, Pages 477-479

  Paci, Eugenio ^a   Rossi, Paolo Giorgi ^a  

^a Public Health Agency for the Lazio Region   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGE; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIGITAL MAMMOGRAPHY; EDITORIAL; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; INDIVIDUALIZATION; MAMMOGRAPHY; MASS SCREENING; PREMENOPAUSE; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; BREAST TUMOR; EARLY DIAGNOSIS; METHODOLOGY; PATHOLOGY; PATIENT ATTITUDE; PATIENT SATISFACTION;

AGE FACTORS; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PREMENOPAUSE;

EID: 77954420752     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.10.32     Document Type: Editorial

References (13)

1. US Preventive Services Task Force: Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann. Intern. Med. 151(10), 716-726, W-236 (2009).
2. Schwartz LM, Woloshin S: News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. JAMA 287(23), 3136-3142 (2002). (Pubitemid 34633991)
3. Wald NJ, Chamberlain J, Hackshaw A: European Society of Mastology Consensus Conference on Breast Cancer screening, Paris, 4-5 February 1993: report of the Evaluation Committee. Clin. Oncol. (R. Coll. Radiol.) 6(4), 261-268 (1994). (Pubitemid 24282632)
4. Eckhardt S, Badellino F, Murphy GP: UICC meeting on breast-cancer screening in pre-menopausal women in developed countries. Geneva, 29 September-1 October 1993. Int. J. Cancer 56(1), 1-5 (1994). (Pubitemid 2011832)
5. Moss S: A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group. J. Med. Screen. 6(3), 144-148 (1999). (Pubitemid 29526262)
6. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L; Trial Management Group: Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 368(9552), 2053-2060 (2006). (Pubitemid 44855105)
7. Evans AJ, Kutt E, Record C, Waller M, Moss S: Radiological fndings of screen-detected cancers in a multi-centre randomized, controlled trial of mammographic screening in women from age 40 to 48 years. Clin. Radiol. 61(9), 784-788 (2006). (Pubitemid 44207873)
8. Karsa LV, Anttila A, Ronco G et al.: Cancer Screening in the European Union. Report on the Implementation of the Council Recommendation on Cancer Screening-First Report. European Communities, Luxembourg (2008).
9. Jonsson H, Törnberg S, Nyström L, Lenner P: Service screening with mammography in Sweden-evaluation of effects of screening on breast cancer mortality in age group 40-49 years. Acta Oncol. 39(5), 617-623 (2000).
10. Sasieni P, Cuzick J: The UK breast-screening programme should start at age 47 years. Lancet 362(9379), 246-247 (2003). (Pubitemid 36859948)
11. Distante V, Ciatto S, Frigerio A et al.: Recommendations of a national Italian consensus conference on the opportunity of extending screening service by mammography to 40-49 and 70-74 years of age women. Epidemiol. Prev. 31(1), 15-22 (2007).
12. Kerlikowske K: Evidence-based breast cancer prevention: the importance of individual risk. Ann, Intern. Med. 151(10), 750-752 (2009).
13. Cuzick J: Assessing risk for breast cancer. Breast Cancer Res. 10(Suppl. 4), S13 (2008).